다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

NVAX

Novavax (NVAX)

Novavax Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:NVAX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/15	05:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NVAX	Novavax Inc
2024/06/15	05:11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NVAX	Novavax Inc
2024/06/15	05:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NVAX	Novavax Inc
2024/06/15	05:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NVAX	Novavax Inc
2024/06/15	05:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NVAX	Novavax Inc
2024/06/15	05:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NVAX	Novavax Inc
2024/06/15	05:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NVAX	Novavax Inc
2024/06/15	05:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NVAX	Novavax Inc
2024/06/15	03:05	PR Newswire (US)	Novavax Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine	NASDAQ:NVAX	Novavax Inc
2024/06/06	20:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NVAX	Novavax Inc
2024/06/05	10:35	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:NVAX	Novavax Inc
2024/05/30	22:25	PR Newswire (US)	Novavax to Participate in 2024 Jefferies Global Healthcare Conference	NASDAQ:NVAX	Novavax Inc
2024/05/24	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NVAX	Novavax Inc
2024/05/21	03:42	Edgar (US Regulatory)	Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material	NASDAQ:NVAX	Novavax Inc
2024/05/20	19:35	GlobeNewswire Inc.	Shah Capital Withdraws Proxy Campaign Against Re-Election of Directors at Novavax’s 2024 Annual Meeting	NASDAQ:NVAX	Novavax Inc
2024/05/20	19:09	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:NVAX	Novavax Inc
2024/05/16	10:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NVAX	Novavax Inc
2024/05/15	06:02	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:NVAX	Novavax Inc
2024/05/14	05:10	Edgar (US Regulatory)	Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material	NASDAQ:NVAX	Novavax Inc
2024/05/14	05:02	PR Newswire (US)	Novavax to Participate in BofA Securities 2024 Health Care Conference	NASDAQ:NVAX	Novavax Inc
2024/05/14	03:39	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NVAX	Novavax Inc
2024/05/10	21:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NVAX	Novavax Inc
2024/05/10	21:05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NVAX	Novavax Inc
2024/05/10	21:02	IH Market News	Novavax Surges 57% Post $1.4 Billion Sanofi Deal; Apple Boosts Data Centers with AI and Internal Chips, and More News	NASDAQ:NVAX	Novavax Inc
2024/05/10	15:15	PR Newswire (US)	Novavax Reports First Quarter 2024 Financial Results and Operational Highlights	NASDAQ:NVAX	Novavax Inc
2024/05/10	15:00	PR Newswire (US)	Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination Vaccines	NASDAQ:NVAX	Novavax Inc
2024/05/09	05:53	Edgar (US Regulatory)	Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material	NASDAQ:NVAX	Novavax Inc
2024/05/08	06:21	Edgar (US Regulatory)	Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material	NASDAQ:NVAX	Novavax Inc
2024/05/08	03:43	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:NVAX	Novavax Inc
2024/05/07	22:25	PR Newswire (US)	Novavax to Host Conference Call to Discuss First Quarter 2024 Financial Results and Operational Highlights on May 10, 2024	NASDAQ:NVAX	Novavax Inc

검색 관련기사 보기:NASDAQ:NVAX

1 2 3 4 5 6 7 8 9 10 다음 >>

Gold vs US Dollar

Verizon Communications

Invesco QQQ Trust Series 1

US Dollar vs Yen

BNP Paribas (QX)

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관